A Clinical Trial to Prevent the Complications of Insulin Resistance (Including Type-2 Diabetes)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The goal of this study is to aggressively treat insulin resistance and its clinical
manifestations when they first appear in childhood, and to prevent the subsequent progression
towards impaired glucose tolerance and type-2 diabetes. In the process of this clinical
trial, we will learn more about the early manifestations of insulin resistance, its
treatment, and its relationship to obesity and type-2 diabetes through parallel in-vivo and
in-vitro studies.